central nervous system

Bionaut treatment platform deploys remote-controlled microscale robots capable of delivering therapies locally to inaccessible disease areas,…

Qynapse Inc., a medical technology company with a commercialized Artificial Intelligence (AI) powered neuroimaging analysis platform for central…

OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic…

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients…

Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders,…

Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders,…

Beacon Biosignals and Cyclerion to Extend and Expand Partnership on Data Collection and Analytics Strategy to Facilitate Development of Cyclerion…

BIOASIS TECHNOLOGIES INC., a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB platform technology for the delivery…

Acquisition Enables Epam to Build Integrated Consulting and Engineering Teams Around a Larger Global Footprint--Transforming Businesses, Using…

Atomwise unveils a growing portfolio of emerging joint venture companies, with programs spanning oncology, immunology, infectious disease,…